The effect of human platelets on the adhesion of polymorphonuclear leukocytes (PMNs) to cultured endothelial cells was investigated. Resting platelets inhibited the adhesion of PMNs stimulated by JV-formyl-methionyl-leucyl-phenylalanine (fMLP), leukotriene B 4 (LTB 4 ), and tumor necrosis factor-or (TNF-cr). Platelets similarly inhibited PMN adhesion induced by endothelial cell activation with TNF-o. The inhibitory effect depended on platelet number, was not associated with detectable platelet activation, and was also exerted by paraformaldehyde-fixed platelets. Moreover, supernatants of U46619-or thrombin-stimulated platelets were ineffective, thus excluding a role for constituents released as a result of the platelet-release reaction. Strong inhibition of PMN adhesion was exerted by platelet lysates. The inhibitory activity associated with lysates was sedimentable, heat sensitive, and not dialyzable through a membrane with a molecular-weight cutoff of 8,000; it was directed toward PMNs and was not due to cytotoxic effects or a general inhibition of PMN responsiveness to stimulation, since enzymatic release from activated PMNs was unaffected by platelet lysates. Finally, the activity was not prevented by specific adenosine inhibitors and anti-P-selectin monoclonal antibody. These data suggest that resting platelets can exert an inhibitory effect on PMN adhesion to the vessel wall during inflammatory and thrombotic
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The effect of human platelets on the adhesion of polymorphonuclear leukocytes (PMNs) to cultured endothelial cells was investigated. Resting platelets inhibited the adhesion of PMNs stimulated by JV-formyl-methionyl-leucyl-phenylalanine (fMLP), leukotriene B 4 (LTB 4 ), and tumor necrosis factor-or (TNF-cr). Platelets similarly inhibited PMN adhesion induced by endothelial cell activation with TNF-o. The inhibitory effect depended on platelet number, was not associated with detectable platelet activation, and was also exerted by paraformaldehyde-fixed platelets. Moreover, supernatants of U46619-or thrombin-stimulated platelets were ineffective, thus excluding a role for constituents released as a result of the platelet-release reaction. Strong inhibition of PMN adhesion was exerted by platelet lysates. The inhibitory activity associated with lysates was sedimentable, heat sensitive, and not dialyzable through a membrane with a molecular-weight cutoff of 8,000; it was directed toward PMNs and was not due to cytotoxic effects or a general inhibition of PMN responsiveness to stimulation, since enzymatic release from activated PMNs was unaffected by platelet lysates. Finally, the activity was not prevented by specific adenosine inhibitors and anti-P-selectin monoclonal antibody. These data suggest that resting platelets can exert an inhibitory effect on PMN adhesion to the vessel wall during inflammatory and thrombotic conditions. ( 3 mediates the adhesion of polymorphonuclear leukocytes (PMNs) to vascular endothelium, an essential event in acute inflammatory 4 and thrombotic 5 conditions. Several endogenous inhibitors of PMN adhesion have been described: adenosine, prostacyclin, 13-hydroxyoctadecadienoic acid, nitric oxide, interleukin-8, "adherence-inhibiting factors," transforming growth factor-^, soluble P-selectin, and pl5E-related inhibitor. 6 - 15 In addition, PMN adhesion may be influenced by other blood elements, such as erythrocytes 16 and platelets. 16 -18 Therefore, complex interactions between different cells and endogenous substances may regulate leukocyte localization at inflammatory sites.
In this work we studied the role of platelets on PMN adhesion to the endothelium, since a wide array of in vitro interactions occurs between platelets and PMNs (for a review, see Reference 19) . We report that the presence of resting platelets in a physiological range can M.J. Metzelaar, Department of Haematology, University Hospital, Utrecht, The Netherlands; monoclonal antibody against glycoprotein Ilb-HIa complex (AP2) was kindly supplied by Dr. TJ. Kunicki, The Blood Center of Southeastern Wisconsin, Milwaukee, Wis.; and minimal essential medium (MEM) and all other reagents for endothelial cell culture were purchased from GIBCO-Europe, Paisley, UK. TV-2-Hydroxyethylpiperazine-/V'-2-ethanesulfonic acid (HEPES)-Tyrode's buffer (pH 7.4), containing (mM) 129 NaCl, 9.9 NaHCO 3 , 2.8 KC1, 0.8 KH 2 PO«, 0.8 MgCl 2 -6H 2 O, 5.6 dextrose, 1 CaCl 2 , and 10 HEPES, was used in the experiments reported.
Platelets, Platelet-Derived Lysates, and Supernatants
Venous blood (80 ml) from healthy donors who had not received any medication for at least 2 weeks was anticoagulated with 3.8% trisodium citrate. Blood was centrifuged at 150g for 10 minutes to obtain plateletrich plasma, which in turn was centrifuged at 500g for 10 minutes in the presence of 10" 6 M PGE!. Platelets that were resuspended in HEPES-Tyrode's buffer (containing 10" 6 M PGE! and 10" 2 M ethylene glycol-bisOaminoethyl ether)-N,/V,W,N'-tetraacetic acid) were subsequently centrifuged (12,000g for 15 seconds) and resuspended in HEPES-Tyrode's buffer containing 10" 6 M PGE,. Finally, platelets were centrifuged (12,000g for 15 seconds) and resuspended in the same buffer containing 10" 3 M CaCl 2 . Preliminary experiments showed that this washing procedure does not induce detectable platelet activation, as measured by flow cytometry and by the lack of binding of the AC7 antibody, which reportedly interacts only with activated platelets. 20 In some experiments, platelets (lO^ml) were fixed with 3% paraformaldehyde for 1 hour at room temperature. Fixation was stopped by the addition of a solution containing tris(hydroxymethyl)aminomethane and glycine (respectively, 2.5x10"' M and 5x10"' M for 15 minutes at room temperature), and cells were then washed three times in buffer.
To prepare platelet tysates, platelets from different donors were washed, resuspended at 2.4xl0 9 /ml in HEPES-Tyrode's buffer, homogenized in a Teflon-glass homogenizer (4°C, 10 strokes), and subsequently sonicated at 4°C by using 5-second bursts at the power setting of 30% of maximum intensity for 1 minute in a Branson B15 Sonifier (Italscientifica, Milano, Italy). Platelet lysates were centrifuged (12,000g for 2 minutes), and the supernatant was collected, stored at -20^C, and thawed just before use. In some experiments, platelet lysates were ultracentrifuged (100,000g for 1 hour at 4°C) to test the activity of either the fluid or sedimentable phase on PMN adhesion.
To obtain platelet supernatants, platelets (0.3-2.4x 10 9 /ml) were exposed to either U46619 (6x 10" 7 M) or thrombin (1 unit/ml) for 5 minutes (37°C, under constant stirring) and subsequently centrifuged (12,000g for 2 minutes). Supernatants were prepared just before the PMN adhesion assay. Hirudin (4 units/ml) was added to supernatants derived from thrombin-activated platelets.
PMNs
PMNs were isolated from platelet-rich plasma-depleted blood by dextran sedimentation followed by Lymphoprep gradient and hypotonic lysis of erythrocytes. 21 PMNs were washed and resuspended in ice-cold HEPES-Tyrode's buffer. Cell suspensions contained more than 97% viable PMNs, as evaluated by the trypan blue exclusion test. PMNs were used within 2 hours after their isolation.
Endothelial Cells
Endothelial cells isolated from bovine thoracic aorta were cultured in MEM with 15% fetal bovine serum, 10" 2 M HEPES, 2xlO~3 M glutamine, 100 units/ml penicillin, 100 jig/ml streptomycin, and 2.5 /xg/ml Fungizone. Cells were maintained in a 37°C, 5% CO 2 humidified atmosphere and used between four and 10 in vitro passages. For the adhesion assays, endothelial cells detached by brief exposure to trypsin (0.25%)-EDTA (0.022%) were plated and grown to confluence in 96-well plates. 22 In some experiments, endothelium from human umbilical veins was used. 23 
Adhesion of PMNs to Endothelial Cells
PMNs were radiolabeled for 1 hour at room temperature with Na 2
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CrO 4 (1 jtCi/10 6 cells), washed twice, and resuspended in HEPES-Tyrode's buffer. PMNs (SxlO'/well) were then layered on endothelial cells in the presence of platelets (or control buffer) to obtain a final platelet to PMN ratio ranging between 20 and 80. Adhesion was induced by stimulating PMNs with fMLP (lO-'-lO" 6 M), LTB« (100 ng/ml), or TNF-a (100 units/ ml) in the presence or absence of 2.5 /xg/ml cytochalasin B. PMNs were then incubated for 15 minutes at 37°C. Wells were washed three times to remove nonadherent cells, the remaining bound cells were lysed with 0.1% sodium dodecyl sulfate, and individual lysates were then counted in a Beckman Gamma 5500 counter (Fullerton, Calif.). Adherence was also assessed microscopically to verify the radiolabeled PMN-adherence results. 22 PMN adhesion was also induced by endothelial cell activation with TNF-a. 24 Briefly, endothelial cells were exposed to 100 units/ml TNF-a for 4 hours at 37°C; at the end of the incubation time endothelial monolayers were washed twice to remove the stimulus, and resting PMNs were added to the wells for the adhesion assay.
In a series of experiments, PMNs (Sxltf/well) in the presence of different amounts of supernatants derived from either activated or lysated platelets (2.4 x 10'/ml) were layered onto endothelial cells in a final volume of 100 fi\, and adhesion was performed under the experimental conditions described above.
Results

Platelets Inhibit PMN Adhesion to Endothelial Cells
As expected, fMLP (10" 9 -10" 6 M) induced concentration-dependent adhesion of PMNs to endothelial cells, with maximal adhesion being reached at 10~7 M ( Figure  1 ). Addition of autologous platelets reduced PMN adhesion; this inhibition depended on platelet number and was maximal at a platelet to PMN ratio of 80. On the other hand, platelets did not affect fMLP (10~7 M)-induced PMN adhesion to plastic (90 ±3% of maximal adhesion at a platelet to PMN ratio of 80; mean±SEM from three different experiments). Moreover, platelets inhibited the adhesion of PMNs induced by other PMN agonists, such as LTB 4 and TNF-a, either in the presence or absence of cytochalasin B (Table 1) . Higher fMLP-induced adhesion was observed in the presence of cytochalasin B, probably reflecting the general increase of PMN activation. Endothelial cell stimulation with TNF-a (100 units/ml, 4 hours) increased basal PMN adhesion fourfold, and also in this condition, adhesion was strongly reduced by platelets ( Figure 2 ).
To assess whether under our conditions the platelets adhered to activated PMNs, thus mechanically interfering with PMN adhesion, a rosette assay was performed. 25 Briefly, mixed platelet/PMN suspensions (ratio of 80) were stimulated by 10" 7 M fMLP (10 minutes, 37°C) and fixed with 3% paraformaldehyde. One hun- Untreated (-) or cytochalasin B (Cyt B)-treated (2J /ig/ml; +) polymorphonuclear leukocytes (PMNs, 3xlO 6 /ml) were layered onto endothelial cells in the presence or absence of platelets (final platelet to PMN ratio, 80). PMNs were subsequently exposed to the stimuli N-fonnyl-methionyl-leucyl-phenylalanine (fMLP), leukotriene B 4 (LTB 4 ), or tumor necrosis factor-a (TNF-a) or control saline, and adhesion was performed as described in "Methods." Results are expressed as number of adherent PMNs (x 10 3 /well). Data are mcan±SEM of three separate experiments. dred PMNs were scored by phase-contrast microscopy for the presence of PMNs bearing at least two platelets (rosettes). Data from two different experiments showed that only 3 ±2% of PMNs formed rosettes with platelets (whereas as a control, 93 ±4% of PMNs formed rosettes with 0.25 unit/ml thrombin-activated platelets).
Platelet Activation and the Release Reaction Are Not Required for the Inhibitory Effect
Since PMN stimulation could indirectly activate platelets and induce their release reaction, 26 ' 27 we investigated whether this phenomenon could play a role in the platelet-dependent inhibitory effect. PMNs stimulated by fMLP induce platelet activation mainly by the release of the serine protease, cathepsin G. 28 When PMNs were pretreated with the specific cathepsin G inhibitor, eglin C, at a concentration (25 /xg/ml) able to completely block the effect of the enzyme, 29 plateletdependent inhibition of PMN adhesion was not significantly affected. Indeed, adhesion of PMNs stimulated by 10" 7 M fMLP was reduced by platelets to a similar extent either in the presence or absence of eglin C (respectively, 46±3% and 48±5% of maximal adhesion at a platelet to PMN ratio of 80; mean±SEM from three different experiments).
In addition, under our experimental conditions the levels of £-thromboglobulin (240±12 ng/ml) released from platelets coincubated with fMLP (10~7 M)-activated PMNs did not differ from the background release of resting platelets incubated with either buffer (233 ±27 ng/ml) or resting PMNs (230 ±10 ng/ml). In contrast, platelets stimulated by 1 unit/ml thrombin released 2,342±21 ng/ml /3-thromboglobulin (mean±SEM from three different experiments). These data indicate that platelet activation, if any, was very limited.
Furthermore, as reported in Figure 3 , supernatants derived from platelets exposed to either the stable endoperoxide analogue U46619 (6xlO~7 M) or throm-
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Piatelet/PMN (ratio) bin (1 unit/ml) were unable to reduce fMLP-induced PMN adhesion, thus further indicating that the inhibitory activity was not associated with platelet-released products. Incubation of U46619 and thrombin with PMNs in the absence of platelets did not modify fMLP-mediated adhesion (not shown). AP2, a monoclonal antibody directed to glycoprotein Ilb-IIIa and used at a concentration (10 ji.g/10 8 platelets) 10-fold higher than that able to block platelet aggregation induced by thrombin (0.1 unit/10 8 platelets), 30 did not affect platelet-mediated inhibition of fMLP (10~7 M)-induced PMN adhesion (respectively, 59 ±7% and 54±9% inhibition of maximal adhesion in the presence and absence of antibody at a platelet to PMN ratio of 80; mean±SEM from three different experiments). Finally, paraformaldehyde-fixed platelets inhibited fMLP (10~7 M)-induced PMN adhesion to a similar extent as control unfixed platelets (respectively, 57 ±10% and 54±8% inhibition of maximal adhesion at a platelet to PMN ratio of 80; mean±SEM from three different experiments).
Platelet Lysates Inhibit PMN Adhesion to Endothelial Cells
To further characterize the platelet-dependent inhibitory activity, we analyzed the effect of platelet lysates on PMN adhesion. PMN adhesion induced by 10~7 M fMLP was strongly reduced by platelet lysates. Inhibition was concentration dependent and plateaued with 50 p\ lysate derived from 2.4 xlO 9 platelets/ml ( Figure  4) . Moreover, platelet lysates inhibited the adhesion of PMNs induced by LTR, and TNF either in the presence or absence of cytochalasin B ( assay did not modify the inhibitory effect (Table 3 ). In contrast, no inhibition was observed when lysate was added to PMNs after stimulation with 10" 7 M fMLP (Table 3) . Like intact platelets, platelet lysates could also inhibit adhesion of resting PMNs to TNF-a (100 units/ml)-activated endothelial cells (Figure 2) .
When rysates were boiled (for as long as 30 minutes) or ultracentrifuged (100,000g for 1 hour), they largely lost their inhibitory activity on fMLP-induced PMN adhesion (Figure 4 ). The inhibitory activity was retained in the pellet of ultracentifuged rysates resuspended in buffer (82±4% inhibition of maximal adhesion with 50 p\ resuspended pellet; mean±SEM from four different experiments). In contrast, the lysate activity was only slightly affected by dialysis (18 hours at 4°C against HEPES-Tyrode's buffer) through a natural 6 /ml) were layered onto endothelial cells in the presence or absence of platelet lysates (50 fjl). PMNs were subsequently exposed to the stimuli Af-forraylmethionyl-leucyl-phenylalanine (fMLP), leukotriene B 4 (LTB 4 ), or tumor necrosis factor-a (TNF-a) or control saline, and adhesion was performed as described in "Methods." Results are expressed as number of adherent PMNs (xlCP/well). Data are mean±SEM of three separate experiments. Before N-formyl-methionyl-leucyl-phenylalanine (fMLP) stimulation, polymorphonuclear leukocyte (PMN) suspensions (50 jtl) were incubated with 50 jd platelet lysates (final PMN concentration, 3xl(f/Q.\ ml) for the indicated times, layered onto endothelial cells, and immediately stimulated with 10" 7 M fMLP. For the second set of experiments, PMNs (50 /xl) were layered onto endothelial cells and stimulated with 10" 7 M fMLP. At the indicated times, 50 /il platelet lysates was added. Data are mean±SEM of three separate experiments.
cellulose membrane with a molecular-weight cutoff of 8,000 (Figure 4 ). Storage at -20°C for as long as 3 months left the activity unchanged.
The inhibitory effect of platelet lysate was directed to PMNs rather than to endothelial cells. Indeed, pretreatment of PMNs with platelet h/sate followed by washing resulted in a significant reduction of fMLP-induced adhesion, whereas endothelial cell pretreatment was ineffective (Table 4) . Similar results were obtained when evaluating PMN adhesion to TNF-a-activated endothelial cells (Table 4 ). In addition, platelet lysate inhibited, to a similar extent, PMN adhesion to either paraformaldehyde-fixed or untreated endothelial cells (respectively, 87 ±6% and 80 ±7% inhibition of maximal In experiment A, platelet lysate (+) or control buffer ( -) was pretreated with saline, aprotinin, or leupeptin for 30 minutes at room temperature and then added to polymorphonuclear leukocytes (PMNs) (3xlO 6 /ml); adhesion assay was performed as described. For experiment B, platelet lysate (+) or control buffer ( -) was pretreated with saline or ethylene glycol-bisO-aminoethyl ether)-Af,N,Af',A''-tetraacetic acid (EGTA) for 30 minutes at room temperature, then incubated with PMNs (3xlO 6 /ml) for 30 minutes at 37 °C; PMN suspensions were then centrifuged and resuspended in buffer. Data are mean±SEM of three separate experiments. adhesion; mean±SEM from three different experiments). Platelet lysates neither were cytotoxic for PMNs, nor did they affect another PMN functional parameter such as enzymatic release. Indeed,
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Cr release from radiolabeled PMNs was similar when PMNs were incubated with either lysate or buffer (respectively, 3.4±2.2% and 3.6±1.4% of total cell-associated radioactivity after 15 minutes at 37°C; mean±SEM from five different experiments). Moreover, the presence of platelet lysate (up to 50 fi\) did not affect lysozyme release from fMLP (10~7 M)-activated PMNs (not shown), as determined by measuring the lysis of Micrococcus luteus. 31 The inhibitory effect of platelet lysates was not affected by protease inhibitors (Table 5) , suggesting that inhibition was not accounted for by proteolysis of PMN adhesive receptors.
Platelet h/sate did not induce PMN aggregation (3xlO 6 /ml, 15 minutes at 37°C in the absence of stirring), as evaluated by the fall in PMN count recorded by an automatic cell counter (System 8000, Baker Instruments, A. De Mori, Italy). Indeed, the count of either resting PMNs (2.9±0.3xl0 6 /ml) or fMLP(10" 7 M)-activated PMNs (2.7±0.4xl0 6 /ml) was not modified by platelet lysate (2.9±0.2xl0<7ml and 3.0±0.1xl0 6 /ml, respectively, in the absence or presence of the stimulus; mean±SEM from three different experiments). Finally, platelets and platelet lysates inhibited fMLP-induced PMN adhesion to endothelial cells of either bovine or human origin (Table 6) .
Platelet-Dependent Inhibition of PMN Adhesion Is Not Mediated by Either Adenosine or P-Selectin
Since adenosine is a powerful inhibitor of PMN adhesion, 622 we tested whether this molecule, which is present in platelet lysates or is eventually derived from the metabolism of platelet adenine nucleotides by endothelial and PMN ectonucleotidases, 32 could mediate inhibition of PMN adhesion. To this purpose, the adenosine scavenger adenosine deaminase and the competitive adenosine receptor antagonist theophylline were used. Both agents, at concentrations able to reverse the adenosine-dependent inhibition of PMN adhesion, did not affect inhibition induced by platelet lysate ( Figure 5 ).
P-selectin (GMP-140), a constitutive protein of platelet a-granule membranes, supports adhesion of activated platelets to PMNs and monocytes. 33 Since soluble P-selectin inhibits TNF-stimulated PMN adhesion, 14 we examined the possibility that inhibition exerted by the platelet lysate may be mediated by this molecule. However, as shown in Figure 6 , platelet lysates pretreated with the anti-P-selectin monoclonal antibody 2.17 retained their inhibitory activity even when this antibody was used at 195 /ig/ml, a concentration that maximally affected P-selectin-mediated PMN adhesion to thrombin-treated endothelium.
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Discussion
This work reports that resting platelets reduced PMN adhesion to endothelial cells. The results suggest that the inhibitory effect was not associated with detectable platelet activation and was not mediated by constituents released on platelet stimulation. Several lines of evidence support this hypothesis: 1) /3-thromboglobulin release (an index of the platelet-release reaction) remained at background levels under our experimental conditions, 2) inhibition of cathepsin G (the main PMN-derived platelet activator) by eglin C did not modify platelet-dependent inhibition of PMN adhesion, 3) supernatants of either U46619-or thrombin-activated platelets did not inhibit PMN adhesion, and finally, 4) platelets retained their inhibitory activity after fixation with paraformaldehyde.
Platelets may either bind PMNs 35 or form mixed cellular conjugates with them, 36 and this might mechanically interfere with PMN adhesion to endothelial cells. However, platelet adhesion to PMNs (rosettes) was not observed under our experimental conditions, and platelet lysates did not induce PMN aggregation. Platelet inhibitory activity could be recovered in the cell lysates and is sedimentable. This finding, combined with the observation that fixed platelets (those unable to undergo the release reaction and thus to expose internally located proteins) retained the inhibitory activity, suggests that the inhibitor(s) is membrane associated.
The inhibition exerted by platelet lysate was not related to cell toxicity, since no 51 Cr release from PMNs was observed. Furthermore, it was not due to a direct inactivation of fMLP or to an nonspecific inhibition of PMN responsiveness to the stimulus, since another functional activity (lysozyme release) was unaffected by platelet lysates.
Endothelial cells can generate antiadhesive substances, such as adenosine, prostacyclin, 13-hydroxyoctadecadienoic acid, and nitric oxide. 6 -9 Platelets might inhibit PMN adhesion by stimulating endothelial cell production of these substances. However, in our system endothelial cells did not participate in the inhibitory activity of platelets, since PMN adhesion was inhibited even on paraformaldehyde-fixed endothelium. The relation between the activity described herein and other platelet-associated inhibitors is an important issue; however, we have been unable to find correspondence with any previously described agent.
Platelets may inhibit PMN adhesion by releasing substances, such as adherence-inhibiting factors 11 ' 12 and transforming growth factor-/3 13 ; these agents, however, are only released after platelet activation, whereas the platelet activity described in this work is evident with resting platelets and is not present in the supernatant of activated platelets. In addition, adherence-inhibiting factors are cytosolic and granular platelet gh/coproteins able to reduce PMN adhesiveness. Unlike these proteins, the activity described herein was essentially retained in the pellet of ultracentrifuged platelet lysates, was lost in the fluid phase, and was stable up to 3 months.
Transforming growth factor-^ released by platelets can also be excluded, since in contrast to the inhibitor described here, its inhibition of PMN adhesion is mediated by the endothelium and is only evident after at least 6 hours of incubation with these cells. 13 Moreover, platelet activity did not correspond to either nitric oxide or adenosine, since it is very stable and not affected by specific adenosine inhibitors or dialysis (with a membrane cutoff greater than adenosine molecular weight). Soluble P-selectin inhibits TNF-astimulated PMN adhesion and superoxide anion generation.
14 - 37 The platelet-derived inhibitor described here, however, did not correspond to P-selectin, since this molecule is contained in the o-granules and becomes available on platelet surfaces only after cell activation, and more directly, a biologically active monoclonal antibody against P-selectin did not prevent the activity.
In conclusion, we describe here a new platelet-dependent activity that does not require cell activation to become evident. The molecular structure and the mechanism of action of this substance(s), however, remain unknown and require further studies. The finding that platelet inhibition of PMN adhesion also occurred at a physiological platelet to PMN ratio suggests that this phenomenon might have biological relevance and that resting platelets might act as natural negative modulators of PMN adhesion. Thrombocytopenia, observed in pathologies such as the adult respiratory distress syndrome, endocarditis, and burns, 38 -40 might represent a condition associated with the reduction of a potential platelet-related defense mechanism able to control the deleterious consequences of excessive PMN activation.
